Page 2 - Opus Genetics News Today

/PRNewswire/ -- The Foundation Fighting Blindness, the worlds leading organization committed to finding treatments and cures for blinding retinal diseases, is...

Gene therapy clinical trial pipeline constitutes 250+ key companies continuously working towards developing 300+ gene therapies, analyzes DelveInsight LAS VEGAS, Nov. 2, 2022 /PRNewswire/

/PRNewswire/ -- DelveInsights Gene Therapy Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and pipeline...

RESEARCH TRIANGLE PARK, N.C., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-first gene therapy company developing treatments for inherited...

STORY AT-A-GLANCE August 15, 2022, the U.K. became the first country to approve Moderna’s new bivalent COVID booster — Spikevax bivalent — which contains mRNA that codes for the original Wuhan [...]

Virtual event details Opus’ unique and transparent approach to building company centered on patient need, provides update on lead programs in Leber...

Since late last year, messenger RNA for Moderna's COVID-19 vaccines, including its recently reformulated Omicron booster, has been exclusively manufactured by a little known company with significant ties to US intelligence. Earlier this week, the...

Last week, U.K. became first country to approve Moderna’s new bivalent COVID booster — Spikevax bivalent — which contains mRNA codes for original Wuhan strain spike protein and Omicron BA.1 subvariant.

Moderna's newest bivalent booster shot has been given the green light in the UK - and will start ...

The best uncensored news, information, and analysis.